{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:41:59Z","timestamp":1792082519465,"version":"4.4.0"},"reference-count":26,"publisher":"American Psychiatric Association Publishing","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2001,12,1]]},"DOI":"10.1176\/appi.ajp.158.12.1989","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:28:01Z","timestamp":1034360881000},"page":"1989-1992","source":"Crossref","is-referenced-by-count":131,"title":["An Effect-Size Analysis of the Relative Efficacy and Tolerability of Serotonin Selective Reuptake Inhibitors for Panic Disorder"],"prefix":"10.1176","volume":"158","author":[{"given":"Michael W.","family":"Otto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly S.","family":"Tuby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e Y.S.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Coplan JD, Pine DS, Papp LA, Gorman JM: An algorithm-oriented treatment approach for panic disorder. Psychiatr Annals 1996; 26:192-201","DOI":"10.3928\/0048-5713-19960401-09"},{"key":"R15812BGBHJJIC","doi-asserted-by":"crossref","unstructured":"Gould RA, Otto MW, Pollack MH: A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 1995; 15:819-844","DOI":"10.1016\/0272-7358(95)00048-8"},{"key":"R15812BGBCEBJI","doi-asserted-by":"crossref","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62","DOI":"10.1136\/jnnp.23.1.56"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Den Boer JA, Westenberg HGM: Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 1990; 102:85-94","DOI":"10.1007\/BF02245749"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Black DW, Wesner R, Bowers W, Gabel J: A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993; 50:44-50","DOI":"10.1001\/archpsyc.1993.01820130046008"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Hoenhn-Saric R, McLeod DR, Hipsler PA: Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993; 13:321-326","DOI":"10.1097\/00004714-199310000-00004"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soeggard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM: Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167:374-379","DOI":"10.1192\/bjp.167.3.374"},{"key":"R15812BGBBDIBA","doi-asserted-by":"crossref","unstructured":"Sharp DM, Power KG, Simpson RJ, Swanson V, Moodie E, Anstee JA, Ashford JJ: Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Disord 1996; 10:219-242","DOI":"10.1016\/0887-6185(96)00008-4"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Lecrubier Y, Bakker A, Dunbar G, Judge R (Collaborative Paroxetine Panic Study Investigators): A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatr Scand 1997; 95:145-152","DOI":"10.1111\/j.1600-0447.1997.tb00388.x"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Wade AG, Lepola U, Koponne HJ, Pedersen V, Pedersen T: The effect of citalopram in panic disorder. Br J Psychiatry 1997; 170:549-553","DOI":"10.1192\/bjp.170.6.549"},{"key":"R15812BGBJCJAD","doi-asserted-by":"crossref","unstructured":"Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP: Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998; 155:36-42","DOI":"10.1176\/ajp.155.1.36"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Londborg PD, Wolkow R, Smith WT, DuBoff E, England D, Ferguson J, Rosenthal M, Weise C: Sertraline in the treatment of panic disorder: a multi-site, double-blind, placebo-controlled, fixed-dose investigation. Br J Psychiatry 1998; 173:54-60","DOI":"10.1192\/bjp.173.1.54"},{"key":"R15812BGBGBEEC","doi-asserted-by":"crossref","unstructured":"Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD (Fluoxetine Panic Disorder Study Group): Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. Am J Psychiatry 1998; 155:1570-1577","DOI":"10.1176\/ajp.155.11.1570"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Pohl RB, Wolkow RM, Clary CM: Sertraline in the treatment of panic disorder: a double-blind multicenter trial. Am J Psychiatry 1998; 155:1189-1195","DOI":"10.1176\/ajp.155.9.1189"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R: Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry 1998; 55:1010-1016","DOI":"10.1001\/archpsyc.55.11.1010"},{"key":"R15812BGBEBHIF","doi-asserted-by":"crossref","unstructured":"Barlow DH, Gorman JM, Shear MK, Woods SW: Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000; 283:2529-2536","DOI":"10.1001\/jama.283.19.2529"},{"key":"R15812BGBGICDA","unstructured":"Begg CB, Berlin JA: Publication bias: a problem in interpreting medical data. J R Stat Soc 1988; 6:11-30"},{"key":"R15812BGBCFHAD","doi-asserted-by":"crossref","unstructured":"Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet 1991; 337:867-872","DOI":"10.1016\/0140-6736(91)90201-Y"},{"key":"R15812BGBGEEDH","doi-asserted-by":"crossref","unstructured":"Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J: Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Br Med J 1993; 306:683-687","DOI":"10.1136\/bmj.306.6879.683"},{"key":"R15812BGBFAJDH","doi-asserted-by":"crossref","unstructured":"Anderson IM, Tomenson BM: Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Br Med J 1995; 310:1433-1438","DOI":"10.1136\/bmj.310.6992.1433"},{"key":"R15812BGBCFFAA","doi-asserted-by":"crossref","unstructured":"Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D: Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9:47-53; correction, 9:296","DOI":"10.1097\/00004850-199400910-00008"},{"key":"R15812BGBFHAIF","doi-asserted-by":"crossref","unstructured":"Boyer W: Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995; 10:45-49","DOI":"10.1097\/00004850-199503000-00006"},{"key":"R15812BGBJBDDB","unstructured":"Ninan PT: Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine. J Clin Psychiatry 1997; 58:24-31"},{"key":"R15812BGBFFJIH","doi-asserted-by":"crossref","unstructured":"Clark DM, Salkovskis PM, Hackmann A, Middleton H, Pavlos A, Gelder M: A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 1994; 164:759-769","DOI":"10.1192\/bjp.164.6.759"},{"key":"R15812BGBJDCGJ","doi-asserted-by":"crossref","unstructured":"Otto MW, Pollack MH, Maki KM: Empirically supported treatment for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol 2000; 68:556-563","DOI":"10.1037\/\/0022-006X.68.4.556"},{"key":"R15812BGBGGEHD","doi-asserted-by":"crossref","unstructured":"Wilson A, Henry DA: Meta analysis: part 2: assessing the quality of published meta-analyses. Med J Aust 1992; 156:173-187","DOI":"10.5694\/j.1326-5377.1992.tb139704.x"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.12.1989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T20:03:32Z","timestamp":1721851412000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.158.12.1989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12,1]]}},"alternative-id":["10.1176\/appi.ajp.158.12.1989"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.158.12.1989","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12,1]]}}}